We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

The Hidden Nasty in Your FTSE 100 Tracker

50% of your FTSE100 investment is at risk

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

I can understand the allure of a passive investment vehicle such as an FTSE 100 (FTSEINDICES: FTSE) index-tracking fund.

Heck, it’s hard work researching and monitoring investments in individual companies, and any one company could perform badly. For safety, the argument goes, we should diversify by investing in several firms. The trouble then is that the workload increases, so it’s clear to see the mental leap into the ‘wisdom’ of investing in a passive tracker — diversification is sorted; trading costs are reduced, human error and bad decisions are eliminated, and it gives you plenty of time to sit back, toes in the sand, with a pineapple daiquiri in hand.

Should you buy Rolls Royce shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

What could possibly go wrong? I’ll tell you…

Strong and weak sectors

Companies are not all the same. Some are better than others because they operate in better, more resilient sectors. Some industries remain strong no matter what the macro-economic environment throws at them. I’m thinking of sectors such as pharmaceuticals, consumer goods, utilities, tobacco and food retail.

The companies in those sectors tend to remain steady, generating cash flow and paying dividends right through the full turn of economic cycles: companies such as GlaxoSmithKline, SABMiller and National Grid.

Some industries buckle under the onslaught of wintry economic conditions. I’m thinking of sectors such as banking, financial services, commodities, non-food retail, airlines & tourism and house builders.

Within the FTSE 100, the companies in sectors that are vulnerable to cyclical downturns can buckle at the knees when economies dive, slashing their dividends, often scrabbling for capital to repair their balance sheets, and watching their share prices plummet to astonishing lows — companies such as Lloyds Banking Group, Rio Tinto and Marks & Spencer Group.

Disturbing bias

If you add up the market capitalisations of all the companies in the FTSE 100, the combined value stands at about £1,848bn. However, firms from the cyclical sectors make up around £925 billion, almost exactly 50%, of that figure. That’s a shockingly large weighting to the cyclicals and the hidden nasty in your FTSE 100 tracker.

If I wanted to put together a diversified portfolio of shares that could reflect steady growth over years, perhaps to build up a retirement fund, I’d probably avoid the cyclical sectors and companies altogether. Yet, investing in a passive index following the FTSE 100, whilst offering diversification, forces this overweight participation in the cyclicals. And right now is not the time to invest in cyclicals, I’d argue.

Not to buy and hold

The price-to-earnings ratio (P/E) of London’s senior index is around 14.1 and produces a dividend yield of 3.4%. By conventional interpretation that seems like reasonable value.  But is it good value, at this stage of the unfolding macro-economic cycle, for the 50% of the FTSE 100 index generated by cyclical companies?

Stock markets look ahead, and that means the share prices of cyclical firms look ahead, too. As macro-economic cycles mature and unfold into a period of growth, such as now, cyclical company share prices tend to look for the next occurrence of peak-earnings. That will precede the next cyclical decline into the next economic contraction and falling profits for the cyclicals. Share prices in cyclical sectors tend to discount rising profits ahead of the next profit fall, so we see falling forward P/E ratings and a rising forward dividend yields, often presaging share price and dividend collapse.

It’s a roller coaster not worth riding over long periods and is one reason why cyclical share prices can really drag on the performance of the FTSE 100. As a comparison, the FTSE 250 trades on a P/E of about 19.2, suggesting it might have more embedded growth opportunity and less cyclicality within its ranks.

Stymied growth

With cyclical P/E ratings compressing as we work through the macro-economic cycle, any growth within the FTSE 100 index is up against this drag on upwards progress. I reckon the FTSE 100’s forward performance could be flatter than some other indices.

One thing’s for certain, if the macro-economic environment gets colder, the FTSE 100 is heading down, perhaps more so than some of the steadier, more defensive constituents within the ‘good’ 50% of its ranks. That potential exaggeration of movement makes the FTSE 100 a good vehicle for shorting when you judge the time is right, and for buying at cyclical bottoms, just as is the case for any individual cyclical firm.

The FTSE 100 index is most definitely not an investment vehicle to buy and hold for decades, I’d suggest there are much better index opportunities elsewhere for passive investment.

Kevin does not own shares in any companies mentioned in this article. The Motley Fool has recommended GlaxoSmithKline.

More on Investing Articles

Elevated view over city of London skyline
Investing Articles

With a 5.8% yield, how much is needed in a Stocks and Shares ISA for £1,000 of monthly passive income?

Muhammad Cheema looks at British Land and its 5.8% dividend yield. How many of its shares are needed in a…

Read more »

British coins and bank notes scattered on a surface
Investing Articles

Why are these FTSE 100 growth and dividend stocks so cheap?

Searching for the greatest FTSE 100 bargain stocks to buy? Royston Wild picks out two to consider with low PEG…

Read more »

many happy international football fans watching tv
Investing Articles

3 cheap FTSE 250 stocks to consider buying before the 2026 World Cup kicks off

With the World Cup less than a week away, our writer highlights a trio of UK stocks to consider buying.…

Read more »

Finger clicking a button marked 'Buy' on a keyboard
Investing Articles

I’m aggressively buying this S&P 500 growth stock for my ISA while it’s down 40%

This S&P 500 tech stock is well off its highs at the moment. But it may not be at depressed…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

What on earth’s happening to the Barclays share price?

The Barclays share price has been jumping around of late and is up 11% in the past month. Ken Hall…

Read more »

A colourful firework display
Investing Articles

See what £12,000 in explosive JD Sports shares 1 month ago is worth today

After years of doom and gloom, JD sport shares are finally putting on a show. Harvey Jones examines how long…

Read more »

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

The BP share price is on a knife edge – so where does it go next?

Harvey Jones exams why the BP share price has been surprisingly jumpy, even as the oil price spikes. Should investors…

Read more »

Wall Street sign in New York City
Investing Articles

Is the FTSE 100 at risk from an overheated US stock market?

Christopher Ruane explains why the UK market could suffer if its bigger US cousin sinks -- and why he's still…

Read more »